Showing results (201-210 of 232) with videos related to

Sort By:
Pageof 24
Blood|March 28, 2015
The IL-33/ST2 axis augments effector T-cell responses during acute GVHDDawn K Reichenbach, Vincent Schwarze, Benjamin M Matta, et al.
Blood|February 13, 2015
Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantationAntiopi Varelias, Kate H Gartlan, Ellen Kreijveld, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 17, 2018
Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related DonorsHany Elmariah, Yvette L Kasamon, Marianna Zahurak, et al.
Transplantation and Cellular Therapy|March 28, 2024
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHDMuna Qayed, Urvi Kapoor, Scott Gillespie, et al.
Blood|September 12, 2022
Effective treatment of low-risk acute GVHD with itacitinib monotherapyAaron Etra, Alexandra Capellini, Amin Alousi, et al.
Blood Advances|July 1, 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGICYu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, et al.
Transplantation and Cellular Therapy|September 2, 2021
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host DiseaseMakda Getachew Zewde, George Morales, Isha Gandhi, et al.
Blood Immunology & Cellular Therapy|May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRMYu Akahoshi, Nikolaos Katsivelos, Ioannis E Louloudis, et al.
Blood|January 5, 2017
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamideChristopher G Kanakry, Javier Bolaños-Meade, Yvette L Kasamon, et al.
Transplantation and Cellular Therapy|December 12, 2024
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk GroupNikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, et al.
Pageof 24